Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02220686 · ClinicalTrials.gov registry record · NA
Vascular Physician Offer and Report (VAPOR) Trial
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT02220686 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 156 participants.
The verdict
NCT02220686, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual. The doctors where you are being treated have been chosen to either provide: the combination therapy of giving you advice, considering prescribing medications to help you quit smoking, and referring you to a phone quitline, or to continue their usual smoking cessation practices (which may include all, some, or none of the treatments above).
Interventions
- BEHAVIORAL Offer and Report Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02220686
The ClinicalTrials.gov registry entry for NCT02220686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Offer and Report Protocol is the first listed.
NCT02220686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02220686 about?
NCT02220686 is a clinical study titled "Vascular Physician Offer and Report (VAPOR) Trial". The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual. The doctors where you are being treated have been chosen to either provide: the combination...
What is the current status of trial NCT02220686?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2014-08. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02220686?
The interventions under investigation include: Offer and Report Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT02220686?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.